Sugi Predict

Sugi Predict / Compounds / SCHEMBL9966402

SCHEMBL9966402

SCHEMBL9966402

Cc1nc(-c2cccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)c2)cs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 1/20 0.47
▸ LMNA P02545 4/20 0.47
▸ HTT P42858 2/20 0.46
▸ MAPT P10636 3/20 0.46
▸ MEN1 O00255 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ ABL1 P00519 1/20 0.42
▸ SYK P43405 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ CFTR P13569 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9966234 0.91 HDAC1 (0.50) LMNAMAPTMEN1NPC1RAB9A
SCHEMBL17210412 0.90 HDAC1 (0.41) OTUD7BLMNAMAPTMEN1KMT2A
SCHEMBL9966438 0.88 ABL1 (0.43) LMNAMAPTNPC1RAB9AKMT2A
SCHEMBL9966262 0.85 LMNA (0.49) LMNAMAPTNPC1RAB9AHDAC1
SCHEMBL9966517 0.84 HDAC1 (0.44) LMNAMAPTNPC1RAB9AHDAC1
SCHEMBL9966219 0.82 RAB9A (0.50) LMNAMAPTMEN1NPC1RAB9A
SCHEMBL9966464 0.81 ABL1 (0.47) LMNAHTTMAPTMEN1NPC1
SCHEMBL9966534 0.81 ELOVL1 (0.58) LMNAHTTMEN1NPC1RAB9A
SCHEMBL9966462 0.80 HDAC1 (0.45) LMNAMAPTNPC1RAB9AHDAC1
SCHEMBL9966265 0.80 HDAC1 (0.42) LMNAMAPTNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651930-B1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INT (DE) 2015-10-28 — — EP disclosed
EP-2651930-B1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INT (DE) 2015-10-28 — — EP disclosed
US-9073895-B2 Biarylamide inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-07 — — US disclosed
US-9073895-B2 Biarylamide inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-07 — — US disclosed
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 — — US disclosed
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 — — US disclosed
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 — — US disclosed
WO-2012082817-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION LTB4R, LTB4R2, LTC4S OTUD7B 2300/4885LMNA 351/4885HTT 3764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.